or
forgot password

Addressing Stigma in Screening and Diagnostic Delay for Cervical Cancer


N/A
18 Years
70 Years
Not Enrolling
Female
Cervical Cancer Screening

Thank you

Trial Information

Addressing Stigma in Screening and Diagnostic Delay for Cervical Cancer


Inclusion Criteria:



Women will be included if they:

1. have not been diagnosed with any type of cancer

2. are between the ages of 18-70

3. self-identify as being African descended or Latina

4. are able to speak English and/or Spanish

5. acknowledge that a Pap test is currently needed

Exclusion Criteria:

1. Cervical cancer is diagnosed only in women, therefore this study only includes women

2. Women who have been and/or are currently diagnosed with any type of cancer will be
excluded

3. Women with other major medical conditions (e.g. stroke and degenerative illness) will
be excluded

4. During the screening the level of symptomatology for depression and anxiety will be
assessed. Women with severe depression and anxiety will be excluded, but appropriate
psychological follow-up and referral will be provided

5. Women older than 70 years will be excluded

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Evaluation of the ability of the social media intervention "End Stigma End Fear, End Cervical Cancer" to counter stigma of cervical cancer among disadvantaged women who acknowledge needing a Pap test at pre-intervention baseline

Outcome Description:

To evaluate the ability of the social media intervention "End Stigma End Fear, End Cervical Cancer" to counter stigma of cervical cancer, by determining whether, among disadvantaged women who acknowledge needing a Pap test at pre-intervention baseline, degree of exposure to the intervention is associated with the following endpoints at 3 months after the intervention is implemented: post-intervention change in stigma score relative to pre-intervention, and Pap testing (scored as 0=made no attempt, 1=made some attempt but did not get tested, 2=obtained Pap test).

Outcome Time Frame:

3 months after the intervention is implemented

Safety Issue:

No

Principal Investigator

Kimlin Ashing-Giwa, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

City of Hope Medical Center

Authority:

United States: Institutional Review Board

Study ID:

09136

NCT ID:

NCT01287871

Start Date:

January 2011

Completion Date:

October 2012

Related Keywords:

  • Cervical Cancer Screening
  • Cervical Cancer Screening
  • Uterine Cervical Neoplasms

Name

Location
City of Hope Medical Center Duarte, California  91010